OptiNose, Inc.
Item 1(b). | Address of Issuer’s Principal Executive Offices |
1020 Stony Hill Road, Suite 300
Yardley, Pennsylvania 19067
Item 2. | (a) Name of Person |
This statement is filed by the entities and persons listed below, all of whom together are referred to herein as the “Reporting Persons”:
| (i) | Avista Capital Partners II GP, LLC |
| (ii) | Avista Capital Partners II, L.P. |
| (iii) | Avista Capital Partners (Offshore) II, L.P. |
| (iv) | Avista Capital Partners (Offshore)II-A, L.P. |
(b) Address of Principal Business Office or, if none, Residence
All Reporting Persons:
c/o Avista Capital Partners
65 East 55th Street, 18th Floor
New York, NY 10022
(c) Citizenship
Avista Capital Partners II GP, LLC and Avista Capital Partners II, L.P.: Delaware
Avista Capital Partners (Offshore) II, L.P. and Avista Capital Partners (Offshore)II-A, L.P.: Bermuda
(d) Title of Class of Securities
Common Stock, par value $0.001 per share
(e) CUSIP Number
68404V100
Item 3. | If this statement is filed pursuant to§§240.13d-1(b) or240.13d-2(b) or (c), check whether the person filing is a: |
| ☐ | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); |
| ☐ | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); |
| ☐ | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); |
Page 5 of 10